ArticleGut2019

Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts.

Ryan C Ungaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.